USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Green Cross Corporation

USPTO PatentsView assignee record - 40 granted patents across 14 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.8

Avg claims per patent

-24%

5-year grant velocity

The verdict

According to USPTO PatentsView, Green ranks #8,035 of 50,000 tracked US assignees by granted-patent volume, with 40 patents across 14 technology areas.

#8,035
of 50,000 US assignees by volume: Top 43%
by Innovation Score (37.7/100): 13.8
avg claims per patent: -24%
grant velocity, last 5 yrs

Portfolio overview

Green Cross Corporation has been granted 40 US utility patents between 2015 and 2025, placing Green Cross Corporation at #8,035 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 14 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.8 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Green Cross Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Green sits between Ghost Autonomy Inc. (40 patents, rank #8,035) and HZO, Inc. (40 patents, rank #8,043) - the closest US assignees by grant volume. The composite Innovation Score of 37.7/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 16 grants, compared with 21 in the 2015–2019 window, a -24% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Green Cross Corporation's 13.8 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 14 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Ghost Autonomy

40
Guandong Ocean Un…

40
Guardian Europe R…

40
Gunze

40
Guangdong Midea W…

40
Hangzhou ZERO ZER…

40
Heraeus Noblelight

40
HZO

40
Green Cross ◀

40

What this shows Green holds 40 patents at rank #8,039, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Green

By rank, the assignees closest to #8,039 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Green's primary technology class.

Green's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Green Cross Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	12.5%
2016	4	10.0%
2017	1	2.5%
2018	3	7.5%
2019	8	20.0%
2020	4	10.0%
2021	4	10.0%
2022	6	15.0%
2023	2	5.0%
2025partial year	3	7.5%

Which technologies does Green Cross Corporation patent most?

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 28

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 23

C07K - PEPTIDES 21

C07D - HETEROCYCLIC COMPOUNDS 11

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 9

C12Y - ENZYMES 7

B01D - SEPARATION 5

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 3

Y02P - CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS 2

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 2

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 1

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1

Top 14 of 14 technology areas

Grant record at a glance

Portfolio Volume 40 grants

CPC subclasses 14

Avg. claims / grant 13.8

Velocity -24%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#8,035

of 50,000 tracked assignees

Innovation Score

37.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Green Cross Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Green Cross Corporation ranks #8,035 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Green Cross Corporation hold?

Green Cross Corporation holds 40 US utility patents granted between 2015 and 2025, spanning 14 technology areas.

What is Green Cross Corporation's Innovation Score?

Green Cross Corporation has an Innovation Score of 37.7 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Green Cross Corporation focus on?

Green Cross Corporation's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 28 patents. Grants appear in 14 CPC subclasses total.

Is Green Cross Corporation's patent grant rate increasing or decreasing?

Green Cross Corporation's recent grant velocity is -24% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Green Cross Corporation's patents?

Green Cross Corporation's patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Green Cross Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Green's 40 grants land it in the top 43% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Green ranks #8,035 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61P - see who else leads that technology area. A61P leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.